LAS VEGAS, Nov. 12, 2014 /PRNewswire/ -- RAMOIL MANAGEMENT, Ltd (OTCPink: RAMO) wants to honor and support our veterans by announcing that RAMO Bio-Med, Inc., its wholly owned subsidiary, is beginning with controlled clinical testing of "RAMO CBD" and "RAMO THC" formulas for the treatment of Post Traumatic Stress Disorder, commonly known as PTSD.
Said testing will be conducted with and through established clinics, specialized in Pain Management and the treatment of PTSD. Presently, we have confirmation of participation in Southern California and are in discussions with another clinic in Florida to conduct this product testing.
Michael Goeree, Ramoil Management's Chairman, President and Chief Executive Officer, said: "We are proud to be beginning to work with PTSD Patients and are opening talks with a leading national PTSD organization in the hope of making a difference in our veteran's lives by offering them discounts on medicines and even a proposed assistance program."
Dwight Chornomud, Natural Elements Group's President and CEO said: "We too are more than happy to be assisting Ramoil Management and RAMO Bio-Med in this worth while clinical testing."
About Ramoil Management, Ltd.
Ramoil Management, Ltd. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containing nutraceutical vapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients. Through its wholly owned subsidiary, RAMO Bio-Med, Inc., it is operating a "Supercritical CO2 Molecular Extraction" system and is planning to build production facilities and research labs, both domestically and internationally, focused on its own proprietary strain of high CBD – extremely low THC Extraction Facilities (Labs and Manufacturing), for the development, production and sales of CBD extractions, concentrates and medicines.
About Natural Elements Group, Inc.
Natural Elements Group, Inc. is an established California Mutual Benefit Non-Profit Medical Marijuana Collective. Natural Elements Group, Inc. presently operates as a multiple member medical marijuana collective, dispensary and distribution company, with production facilities in both Southern and Northern California.
Forward Looking Statements:
This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
Company and Investor Relations Contact:
Frank Blainey, Esq. at: +1-702-381-1961
SOURCE Ramoil Management, Ltd.